Literature DB >> 16850161

Glucosamine sulfate-induced apoptosis in chronic myelogenous leukemia K562 cells is associated with translocation of cathepsin D and downregulation of Bcl-xL.

Zhe Wang1, Rong Liang, Gao-Sheng Huang, Ying Piao, Yong-Qing Zhang, Ai-Qin Wang, Bao-Xia Dong, Ji-Liang Feng, Guo-Rong Yang, Ying Guo.   

Abstract

Cathepsin D (cat D) reportedly plays an important role in certain apoptotic processes, the downstream pathways of which involve release of cytochrome c (cyt c) from mitochondria and activation of the caspase cascade. Previous studies revealed that the B-cell lymphoma 2 (Bcl-2) family members Bax or Bid play important roles in apoptotic signal transduction between cat D and mitochondria. Here, we show that glucosamine sulfate (GS) inhibits the proliferation and induces apoptosis of human chronic myelogenous leukemia K562 cells in vitro. GS interfered with the maturation of cat D. Activation of caspase-3, cleavage of poly-(ADP-ribose)-polymerase, release of cyt c, and downregulation of Bcl-xL accompanied GS-induced apoptosis, and these processes were inhibited by the cat D inhibitor pepstatin A. However, we did not detect any altered gene expression of Bcl-2, Bax, or Bid during apoptosis. Translocation of cat D from the lysosome to the cytosol was observed in GS-treated K562 cells. These findings suggest that GS-induced K562 cell apoptosis involves the translocation of cat D from the lysosome to the cytosol. Furthermore, our findings suggest that downregulation of Bcl-xL (but not Bcl-2, Bax, or Bid) connects cat D and the mitochondrial pathway, which causes the release of cyt c and activation of the caspase cascade during GS-induced apoptosis of K562 cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16850161     DOI: 10.1007/s10495-006-9529-6

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  4 in total

1.  Anti-proliferative potential of Glucosamine in renal cancer cells via inducing cell cycle arrest at G0/G1 phase.

Authors:  Long-Sheng Wang; Shao-Jun Chen; Jun-Feng Zhang; Meng-Nan Liu; Jun-Hua Zheng; Xu-Dong Yao
Journal:  BMC Urol       Date:  2017-05-30       Impact factor: 2.264

2.  Glucosamine suppresses proliferation of human prostate carcinoma DU145 cells through inhibition of STAT3 signaling.

Authors:  Viktor Chesnokov; Chao Sun; Keiichi Itakura
Journal:  Cancer Cell Int       Date:  2009-09-10       Impact factor: 5.722

3.  Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation.

Authors:  Yueh-Lun Lee; Chih-Wei Chen; Fu-Hwa Liu; Yu-Wen Huang; Huei-Mei Huang
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

4.  The novel IGF-IR/Akt-dependent anticancer activities of glucosamine.

Authors:  Ki-Hoon Song; Ju-Hee Kang; Jong-Kyu Woo; Jeong-Seok Nam; Hye-Young Min; Ho-Young Lee; Soo-Youl Kim; Seung-Hyun Oh
Journal:  BMC Cancer       Date:  2014-01-20       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.